DANIPHARM A/S — Credit Rating and Financial Key Figures

DANIPHARM A/S (CVR number: 12335040) is a company from TÅRNBY. The company recorded a gross profit of 34.1 mDKK in 2023. The operating profit was 7027.8 kDKK, while net earnings were 5113.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 9.2 %, which can be considered good and Return on Equity (ROE) was 11.6 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 48.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. DANIPHARM A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.